Preferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber 'cell highways'

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Nelson, Mark Tyler ^a   Short, Aaron ^a   Cole, Sara L ^b   Gross, Amy C ^b   Winter, Jessica ^a   Eubank, Tim D ^b   Lannutti, John J ^a  

^a The Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cell motility; Chemotaxis; MCF 10A; MCF 7; MDA MB 231; Topography

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; NANOFIBER; STROMAL CELL DERIVED FACTOR 1; BIOMIMETIC MATERIAL; CHEMOTACTIC FACTOR; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BREAST CANCER CELL LINE; CANCER CELL; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; ELECTROSPINNING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR MICROENVIRONMENT; BREAST TUMOR; CELL MOTION; CHEMISTRY; DRUG EFFECTS; EXTRACELLULAR MATRIX; FEMALE; GENETICS; HIGH THROUGHPUT SCREENING; MCF 7 CELL LINE; METASTASIS; PATHOLOGY; SYNTHESIS; TUMOR INVASION; ULTRASTRUCTURE;

BIOMIMETIC MATERIALS; BREAST NEOPLASMS; CELL MOVEMENT; CHEMOKINE CXCL12; CHEMOTACTIC FACTORS; EXTRACELLULAR MATRIX; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MCF-7 CELLS; NANOFIBERS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTORS, CXCR4; RNA, MESSENGER; TUMOR MICROENVIRONMENT;

EID: 84920818236     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-825     Document Type: Article

References (69)

1. Edwards BK, Noone A, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM: Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 2014, 120(9):1290-1314.
2. Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, Nomura Y, Sakai K, Sugimachi K, Tominaga T, Uchino J, Yoshida M, Haybittle JL, Davies C, Harvey VJ, Holdaway TM, Kay RG, Mason BH, Forbes JF, Wilcken N, Gnant M, Jakesz R, Ploner M, Yosef HMA, Focan C, Lobelle JP, Peek U, Oates GD, Powell J, Durand M, et al: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. The Lancet 2005, 365(9472):1687-1717.
3. Boyd NF: Tamoxifen, mammographic density, and breast cancer prevention. J Natl Cancer Inst 2011, 103(9):704-705.
4. Trape AP, Gonzalez-Angulo AM: Breast Cancer and Metastasis: On the Way Toward Individualized Therapy. 2012:9.
5. Anders CK, Zagar TM, Carey LA: The management of early-stage and metastatic triple-negative breast cancer: a review. Hematol Oncol Clin North Am 2013, 27:737-749.
6. Gupta GP, Massagué J: Cancer metastasis: building a framework. Cell 2006, 127:679-695.
7. Chaffer CL, Weinberg RA: A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
8. Baker EL, Srivastava J, Yu D, Bonnecaze RT, Zaman MH: Cancer cell migration: integrated roles of matrix mechanics and transforming potential. PLoS One 2011, 6:e20355.
9. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW: The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 2002, 70.
10. Dhimolea E, Soto AM, Sonnenschein C: Breast epithelial tissue morphology is affected in 3D cultures by species-specific collagenbased extracellular matrix. J Biomed Mater Res Part A 2012, 100A:2905-2912.
11. Adanja I, Debeir O, Megalizzi V, Kiss R, Warzee N, Decaestecker C: Automated tracking of unmarked cells migrating in three-dimensional matrices applied to anti-cancer drug screening. Exp Cell Res 2010, 316.
12. Mok TSK: Personalized medicine in lung cancer: what we need to know. Nat Rev Clin Oncol 2011, 8(11):661-8.
13. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001, 344(11):783-792.
14. Tao L, Hu W, Liu Y, Huang G, Sumer BD, Gao J: Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp Biol Med 2011, 236.
15. Alexander S, Friedl P: Cancer invasion and resistance: interconnected processes of disease progression and therapy failure. Trends Mol Med 2012, 18:13-26.
16. Mahamodhossen YA, Liu W, Rong-Rong Z: Triple-negative breast cancer: new perspectives for novel therapies. Med Oncol 2013, 30:653.
17. Noonan DM, Pennesi G, Albini A: Invasion and Metastasis. 2010:213-228.
18. Shibue T, Weinberg RA: Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol 2011, 21:99-106.
19. Spano D, Zollo M: Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis 2012, 29:381-395.
20. Friedl P, Alexander S: Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
21. Hansen RK, Bissell MJ: Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer 2000, 7.
22. Nguyen-Ngoc K-V, Cheunga KJ, Brenot A, Shamir ER, Gray RS, Hines WC, Yaswen P, Werb Z, Ewald AJ: ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A 2012, 109(39):E2595-E2604.
23. Alexander S, Weigelin B, Winkler F, Friedl P: Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response. Curr Opin Cell Biol 2013, 25:659-671.
24. Gritsenko PG, Ilina O, Friedl P: Interstitial guidance of cancer invasion. J Pathol 2012, 226:185-199.
25. Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ: Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 2011, 178(3):1221-1232.
26. Ilina O, Bakker G, Vasaturo A, Hofmann RM, Friedl P: Two-photon laser-generated microtracks in 3D collagen lattices: principles of MMP-dependent and-independent collective cancer cell invasion. Phys Biol 2011, 8:015010.
27. Provenzano PP, Eliceiri KW, Inman DR, Keely PJ: Engineering Three-Dimensional Collagen Matrices to Provide Contact Guidance During 3D Cell Migration. 2010:Chapter 10.
28. Provenzano PP, Inman DR, Eliceiri KW, Trier SM, Keely PJ: Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCKdependent matrix reorganization. Biophys J 2008, 95:5374-5384.
29. Tamimi SO, Ahmed A: Stromal changes in invasive breast-carcinoma-an ultrastructural-study. J Pathol 1987, 153(2):163.
30. Conklin MW, Keely PJ: Why the stroma matters in breast cancer insights into breast cancer patient outcomes through the examination of stromal biomarkers. Celll Adhes Migr 2012, 6:249-260.
31. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ: Collagen reorganization at the tumor-stromal interface facilitates local invasion. 2006, 4:38.
32. Abraham LC, Dice JF, Finn PF, Mesires NT, Lee K, Kaplan DL: Extracellular matrix remodeling-methods to quantify cell-matrix interactions. Biomaterials 2007, 28:151-161.
33. Agudelo-Garcia PA, De Jesus JK, Williams SP, Nowicki MO, Chiocca EA, Liyanarachchi S, Li PK, Lannutti JJ, Johnson JK, Lawler SE, Viapiano MS: Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling. Neoplasia 2011, 13(9):831-U96.
34. Eisenberg MC, Kim Y, Li R, Ackerman WE, Kniss DA, Friedman A: Mechanistic modeling of the effects of myoferlin on tumor cell invasion. PNAS 2011, 108:20078-20083.
35. Haessler U, Teo JCM, Foretay D, Renaud P, Swartz MA: Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr Biol 2012, 4:401-409.
36. Johnson J, Nowicki MO, Lee CH, Chiocca EA, Viapiano MS, Lawler SE, Lannutti JJ: Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy. Tissue Eng Part C: Methods 2009, 15:531-540.
37. Rao SS, Nelson MT, Xue R, DeJesus JK, Viapiano MS, Lannutti JJ, Sarkar A, Winter JO: Mimicking white matter tract topography using core-shell electrospun nanofibers to examine migration of malignant brain tumors. Biomaterials 2013, 34(21):5181-5190.
38. Beachley V, Wen XJ: Effect of electrospinning parameters on the nanofiber diameter and length. Mater Sci Eng C 2009, 29:663-668.
39. Johnson J, Ghosh A, Lannutti J: Microstructure-property relationships in a tissue-engineering scaffold. J Appl Polym Sci 2007, 104.
40. Powell HM, Boyce ST: Engineered Human Skin Fabricated Using Electrospun Collagen-PCL Blends: Morphogenesis and Mechanical Properties. 2009:15.
41. Schnell E, Klinkhammer K, Balzer S, Brook G, Klee D, Dalton P, Mey J: Guidance of glial cell. migration and axonal growth on electrospun nanofibers of poly-epsilon-caprolactone and a collagen/poly-epsiloncaprolactone blend. Biomaterials 2007, 28:3012-3025.
42. Holliday DL, Speirs V: Choosing the right cell line for breast cancer research. Breast Cancer Res 2011, 13:215.
43. Gaumer J, Prasad A, Lee D, Lannutti J: Source-to-ground distance and the mechanical properties of electrospun fiber. Acta Biomater 2009, 5:1552-1561.
44. Nam J, Huang Y, Agarwal S, Lannutti J: Materials selection and residual solvent retention in biodegradable electrospun fibers. J Appl Polym Sci 2008, 107.
45. Bissell MJ, Rizki A, Mian IS: Tissue architecture: the ultimate regulator of breast epithelial function-commentary. Curr Opin Cell Biol 2003, 15.
46. Andrews JL, Kim AC, Hens JR: The role and function of cadherins in the mammary gland. Breast Cancer Res 2012, 14:203.
47. Raviraj V, Zhang H, Chien H, Cole L, Thompson EW, Soon L: Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas. Clin Exp Metastasis 2012, 29.
48. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ: Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 2009, 28.
49. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, White JG, Keely PJ: Collagen density promotes mammary tumor initiation and progression. BMC Med 2008, 6:11.
50. Eubank TD, Roberts RD, Khan M, Curry JM, Nuovo GJ, Kuppusamyl P, Marsh CB: Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res 2009, 69:2133-2140.
51. Guiet R, Van Goethem E, Cougoule C, Balor S, Valette A, Al Saati T, Lowell CA, Le Cabec V, Maridonneau-Parini I: The Process of Macrophage Migration Promotes Matrix Metalloproteinase-Independent Invasion by Tumor Cells. J Immunol 2011, 187:3806.
52. Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J, Pollard JW: Macrophages Promote Collagen Fibrillogenesis Around Terminal End Buds of the Developing Mammary Gland. 2006:235.
53. Krol M, Pawlowski KM, Majchrzak K, Dolka I, Abramowicz A, Szyszko K, Motyl T: Density of tumor-associated macrophages (TAMs) and expression of their growth factor receptor MCSF-R and CD14 in canine mammary adenocarcinomas of various grade of malignancy and metastasis. Pol J Vet Sci 2011, 14:3-10.
54. Chung AS, Waldeck H, Schmidt DR, Kao WJ: Monocyte inflammatory and matrix remodeling response modulated by grafted ECM-derived ligand concentration. J Biomed Mater Res A 2009, 91A:742-752.
55. Koch TM, Muenster S, Bonakdar N, Butler JP, Fabry B: 3D traction forces in cancer cell invasion. PLoS One 2012, 7:e33476.
56. Kumar G, Co CC, Ho C: Steering cell migration using microarray amplification of natural directional persistence. Langmuir 2011, 27.
57. Horimoto Y, Polanska UM, Takahashi Y, Orimo A: Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr 2012, 6(3):193-202.
58. Scheel C, Weinberg RA: Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012, 22.
59. Takebe N, Warren RQ, Ivy SP: Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 2011, 13:211.
60. Yao D, Dai C, Peng S: Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 2011, 9:1608-1620.
61. Jin F, Brockmeier U, Otterbach F, Metzen E: New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation. Mol Cancer Res 2012, 10:1021-1031.
62. Boimel PJ, Smirnova T, Zhou ZN, Wyckoff J, Park H, Coniglio SJ, Qian B, Stanley ER, Cox D, Pollard JW, Muller WJ, Condeelis J, Segall JE: Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res 2012, 14(1):R23.
63. Williams SA, Harata-Lee Y, Comerford I, Anderson RL, Smyth MJ, McColl SR: Multiple functions of CXCL12 in a syngeneic model of breast cancer. Mol Cancer 2010, 9:250.
64. Zhuo W, Jia L, Song N, Lu X, Ding Y, Wang X, Song X, Fu Y, Luo Y: The CXCL12-CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis. Clin Cancer Res 2012, 18:19.
65. De Oliveira KB, Guembarovski RL, Fiorina Losi Guembarovski AM, da Silva do Amaral Herrera AC, Jorge Sobrinho W, Ariza CB, Ehara Watanabe MA: CXCL12, CXCR4 and IFN gamma genes expression: implications for proinflammatory microenvironment of breast cancer. Clin Exp Med 2013, 13:211-219.
66. Arriagada R, Lê MG, Contesso G, Guinebretière JM, Rochard F, Spielmann M: Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 2002, 13:1404-1413.
67. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007, 13(15):4429-4434.
68. Haka AS, Volynskaya Z, Gardecki JA, Nazemi J, Lyons J, Hicks D, Fitzmaurice M, Dasari RR, Crowe JP, Feld MS: In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy. Cancer Res 2006, 66(6):3317-3322.
69. Muehlberg FL, Song Y, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB, Alt EU: Tissueresident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009, 30(4):589-597.